US Stock MarketDetailed Quotes

XERS Xeris Pharmaceuticals

Watchlist
  • 1.700
  • -0.060-3.41%
Close Apr 25 16:00 ET
  • 1.710
  • +0.010+0.59%
Post 18:54 ET
252.03MMarket Cap-3777P/E (TTM)

Xeris Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
48.68%163.91M
33.93%44.39M
62.56%48.32M
50.19%38.01M
50.39%33.2M
122.32%110.25M
54.67%33.14M
168.76%29.73M
184.15%25.31M
169.35%22.07M
Operating revenue
48.68%163.91M
33.93%44.39M
62.56%48.32M
50.19%38.01M
50.39%33.2M
122.32%110.25M
54.67%33.14M
168.76%29.73M
184.15%25.31M
169.35%22.07M
Cost of revenue
26.56%28.65M
20.33%7.57M
55.91%8.2M
57.07%7.56M
-15.21%5.32M
69.95%22.63M
28.68%6.29M
63.35%5.26M
42.18%4.81M
243.54%6.27M
Gross profit
54.39%135.27M
37.12%36.82M
63.99%40.12M
48.58%30.45M
76.44%27.88M
141.55%87.61M
62.35%26.85M
212.05%24.47M
271.10%20.5M
148.08%15.8M
Operating expense
5.74%179.28M
11.04%46.66M
4.13%45.03M
17.81%46.43M
-8.29%41.15M
11.97%169.55M
-35.16%42.02M
34.31%43.25M
25.88%39.41M
94.18%44.87M
Selling and administrative expenses
6.06%146.1M
9.35%37.57M
8.11%37.29M
14.10%37.64M
-6.43%33.61M
9.57%137.75M
-36.59%34.36M
29.98%34.49M
27.22%32.98M
88.25%35.91M
Research and development costs
6.56%22.34M
28.80%6.38M
-16.70%5.03M
63.72%6.09M
-22.59%4.84M
-16.67%20.97M
-50.85%4.96M
6.71%6.04M
-30.93%3.72M
55.01%6.25M
Depreciation amortization depletion
0.00%10.84M
0.00%2.71M
0.00%2.71M
0.00%2.71M
0.00%2.71M
1,871.45%10.84M
392.91%2.71M
--2.71M
--2.71M
--2.71M
-Depreciation and amortization
0.00%10.84M
0.00%2.71M
0.00%2.71M
0.00%2.71M
0.00%2.71M
1,871.45%10.84M
392.91%2.71M
--2.71M
--2.71M
--2.71M
Operating profit
46.29%-44.01M
35.13%-9.84M
73.84%-4.91M
15.53%-15.98M
54.33%-13.28M
28.84%-81.94M
68.57%-15.17M
22.90%-18.78M
26.65%-18.92M
-73.68%-29.07M
Net non-operating interest income expense
-89.67%-21.86M
-134.19%-5.91M
-62.81%-5.73M
-63.08%-5.31M
-42.37%-4.92M
-67.82%-11.52M
-46.23%-2.52M
-103.06%-3.52M
-89.35%-3.25M
-104.20%-3.45M
Non-operating interest income
84.29%4.75M
-39.93%1.11M
137.50%1.12M
527.18%1.22M
1,811.76%1.3M
723.64%2.58M
2,532.86%1.84M
615.15%472K
153.25%195K
-32.00%68K
Non-operating interest expense
88.69%26.61M
60.71%7.02M
71.65%6.85M
89.33%6.53M
76.54%6.22M
96.41%14.1M
143.15%4.37M
121.86%3.99M
92.09%3.45M
96.59%3.52M
Other net income (expense)
190.23%2.36M
-51.97%2.13M
-1,586.61%-1.89M
117.61%767K
185.20%1.36M
-273.22%-2.62M
658.13%4.43M
56.79%127K
-43,450.00%-4.36M
-8,075.00%-1.6M
Gain on sale of security
-99.94%1K
-114.29%-2K
88.89%17K
-102.71%-14K
----
350.71%1.76M
101.77%14K
-88.89%9K
5,260.00%516K
6,005.00%1.22M
Special income (charges)
153.95%2.36M
-51.77%2.13M
-1,714.41%-1.91M
116.03%781K
148.26%1.36M
---4.38M
--4.41M
--118K
---4.87M
---2.82M
-Less：Restructuring and merger&acquisition
-264.71%-5.2M
51.77%-2.13M
-689.83%-932K
-116.03%-781K
-148.26%-1.36M
--3.16M
---4.41M
---118K
--4.87M
--2.82M
-Less:Other special charges
131.97%2.84M
--0
--2.84M
----
----
--1.22M
--0
----
----
----
Income before tax
33.91%-63.5M
-2.70%-13.63M
43.50%-12.53M
22.65%-20.52M
50.67%-16.83M
21.71%-96.08M
73.88%-13.27M
14.76%-22.17M
3.60%-26.52M
-85.33%-34.12M
Income tax
12.29%-1.25M
30.18%-236K
0.29%-338K
-99.12%-675K
0
-1.42M
-338K
-339K
-339K
-408K
Net income
34.23%-62.26M
-3.56%-13.39M
44.17%-12.19M
24.22%-19.84M
50.07%-16.83M
22.87%-94.66M
74.54%-12.93M
16.06%-21.83M
4.83%-26.19M
-83.12%-33.71M
Net income continuous Operations
34.23%-62.26M
-3.56%-13.39M
44.17%-12.19M
24.22%-19.84M
50.07%-16.83M
22.87%-94.66M
74.54%-12.93M
16.06%-21.83M
4.83%-26.19M
-83.12%-33.71M
Minority interest income
Net income attributable to the parent company
34.23%-62.26M
-3.56%-13.39M
44.17%-12.19M
24.22%-19.84M
50.07%-16.83M
22.87%-94.66M
74.54%-12.93M
16.06%-21.83M
4.83%-26.19M
-83.12%-33.71M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
34.23%-62.26M
-3.56%-13.39M
44.17%-12.19M
24.22%-19.84M
50.07%-16.83M
22.87%-94.66M
74.54%-12.93M
16.06%-21.83M
4.83%-26.19M
-83.12%-33.71M
Basic earnings per share
35.71%-0.45
10.00%-0.09
43.75%-0.09
26.32%-0.14
52.00%-0.12
54.84%-0.7
76.19%-0.1
58.97%-0.16
53.66%-0.19
16.67%-0.25
Diluted earnings per share
35.71%-0.45
10.00%-0.09
43.75%-0.09
26.32%-0.14
52.00%-0.12
54.84%-0.7
76.19%-0.1
58.97%-0.16
53.66%-0.19
16.67%-0.25
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 48.68%163.91M33.93%44.39M62.56%48.32M50.19%38.01M50.39%33.2M122.32%110.25M54.67%33.14M168.76%29.73M184.15%25.31M169.35%22.07M
Operating revenue 48.68%163.91M33.93%44.39M62.56%48.32M50.19%38.01M50.39%33.2M122.32%110.25M54.67%33.14M168.76%29.73M184.15%25.31M169.35%22.07M
Cost of revenue 26.56%28.65M20.33%7.57M55.91%8.2M57.07%7.56M-15.21%5.32M69.95%22.63M28.68%6.29M63.35%5.26M42.18%4.81M243.54%6.27M
Gross profit 54.39%135.27M37.12%36.82M63.99%40.12M48.58%30.45M76.44%27.88M141.55%87.61M62.35%26.85M212.05%24.47M271.10%20.5M148.08%15.8M
Operating expense 5.74%179.28M11.04%46.66M4.13%45.03M17.81%46.43M-8.29%41.15M11.97%169.55M-35.16%42.02M34.31%43.25M25.88%39.41M94.18%44.87M
Selling and administrative expenses 6.06%146.1M9.35%37.57M8.11%37.29M14.10%37.64M-6.43%33.61M9.57%137.75M-36.59%34.36M29.98%34.49M27.22%32.98M88.25%35.91M
Research and development costs 6.56%22.34M28.80%6.38M-16.70%5.03M63.72%6.09M-22.59%4.84M-16.67%20.97M-50.85%4.96M6.71%6.04M-30.93%3.72M55.01%6.25M
Depreciation amortization depletion 0.00%10.84M0.00%2.71M0.00%2.71M0.00%2.71M0.00%2.71M1,871.45%10.84M392.91%2.71M--2.71M--2.71M--2.71M
-Depreciation and amortization 0.00%10.84M0.00%2.71M0.00%2.71M0.00%2.71M0.00%2.71M1,871.45%10.84M392.91%2.71M--2.71M--2.71M--2.71M
Operating profit 46.29%-44.01M35.13%-9.84M73.84%-4.91M15.53%-15.98M54.33%-13.28M28.84%-81.94M68.57%-15.17M22.90%-18.78M26.65%-18.92M-73.68%-29.07M
Net non-operating interest income expense -89.67%-21.86M-134.19%-5.91M-62.81%-5.73M-63.08%-5.31M-42.37%-4.92M-67.82%-11.52M-46.23%-2.52M-103.06%-3.52M-89.35%-3.25M-104.20%-3.45M
Non-operating interest income 84.29%4.75M-39.93%1.11M137.50%1.12M527.18%1.22M1,811.76%1.3M723.64%2.58M2,532.86%1.84M615.15%472K153.25%195K-32.00%68K
Non-operating interest expense 88.69%26.61M60.71%7.02M71.65%6.85M89.33%6.53M76.54%6.22M96.41%14.1M143.15%4.37M121.86%3.99M92.09%3.45M96.59%3.52M
Other net income (expense) 190.23%2.36M-51.97%2.13M-1,586.61%-1.89M117.61%767K185.20%1.36M-273.22%-2.62M658.13%4.43M56.79%127K-43,450.00%-4.36M-8,075.00%-1.6M
Gain on sale of security -99.94%1K-114.29%-2K88.89%17K-102.71%-14K----350.71%1.76M101.77%14K-88.89%9K5,260.00%516K6,005.00%1.22M
Special income (charges) 153.95%2.36M-51.77%2.13M-1,714.41%-1.91M116.03%781K148.26%1.36M---4.38M--4.41M--118K---4.87M---2.82M
-Less：Restructuring and merger&acquisition -264.71%-5.2M51.77%-2.13M-689.83%-932K-116.03%-781K-148.26%-1.36M--3.16M---4.41M---118K--4.87M--2.82M
-Less:Other special charges 131.97%2.84M--0--2.84M----------1.22M--0------------
Income before tax 33.91%-63.5M-2.70%-13.63M43.50%-12.53M22.65%-20.52M50.67%-16.83M21.71%-96.08M73.88%-13.27M14.76%-22.17M3.60%-26.52M-85.33%-34.12M
Income tax 12.29%-1.25M30.18%-236K0.29%-338K-99.12%-675K0-1.42M-338K-339K-339K-408K
Net income 34.23%-62.26M-3.56%-13.39M44.17%-12.19M24.22%-19.84M50.07%-16.83M22.87%-94.66M74.54%-12.93M16.06%-21.83M4.83%-26.19M-83.12%-33.71M
Net income continuous Operations 34.23%-62.26M-3.56%-13.39M44.17%-12.19M24.22%-19.84M50.07%-16.83M22.87%-94.66M74.54%-12.93M16.06%-21.83M4.83%-26.19M-83.12%-33.71M
Minority interest income
Net income attributable to the parent company 34.23%-62.26M-3.56%-13.39M44.17%-12.19M24.22%-19.84M50.07%-16.83M22.87%-94.66M74.54%-12.93M16.06%-21.83M4.83%-26.19M-83.12%-33.71M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 34.23%-62.26M-3.56%-13.39M44.17%-12.19M24.22%-19.84M50.07%-16.83M22.87%-94.66M74.54%-12.93M16.06%-21.83M4.83%-26.19M-83.12%-33.71M
Basic earnings per share 35.71%-0.4510.00%-0.0943.75%-0.0926.32%-0.1452.00%-0.1254.84%-0.776.19%-0.158.97%-0.1653.66%-0.1916.67%-0.25
Diluted earnings per share 35.71%-0.4510.00%-0.0943.75%-0.0926.32%-0.1452.00%-0.1254.84%-0.776.19%-0.158.97%-0.1653.66%-0.1916.67%-0.25
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg